Columbia Psychiatry Pathways 3.28.7

avoMD, Inc – Freeware – iOS
從 29 票

最新版本
3.28.7 安全安裝

這不是一個下載表格！

UpdateStar 程式資料庫是由使用者維護、提供給使用者。
有了您的支持，你可以協助其他使用者使他們的軟體保持最新。填寫任何那些不正確或老舊的欄位。我們將儘快檢查並評估您的貢獻。
謝謝您支持 UpdateStar！

標題：

分類：

需求：

Android

iOS

Windows

Mac

Linux

授權：

發行者：

發行者網址：

描述：

Developed by expert psychiatrists from Columbia University and powered by avoMD's state-of-the-art interactive technology, this evidence-based application offers a pragmatic and user-friendly treatment algorithm for major depression.

The app integrates Columbia’s Accelerated Sequential Antidepressant Protocol (ASAP) © 2021 The Trustees of Columbia University in the City of New York. It includes tools to evaluate depression severity (PHQ-9 and Columbia Depression Scale), conduct bipolar screenings, and assess suicide risk, consolidating all essential information for managing depression in one easily accessible platform. Additionally, it features clinical insights on antidepressant titration and the management of common side effects.

A modernized version of the STAR*D Trial from 2006, ASAP emphasizes prompt titrations and follow-ups centered around the seven best-tolerated generic antidepressants, streamlining the process of treating depression.

Targeted for utilization in outpatient settings by psychiatrists, primary care physicians, nurse practitioners, physician assistants, medical students, residents, and trainees dealing with patients suffering from depression, Columbia Psychiatry Pathways serves as a valuable resource.

<ul>
<li>Developed by experts at Columbia University's Department of Psychiatry in collaboration with avoMD</li>
<li>Regularly updated to align with the most recent research findings and supplemented with external resources</li>
<li>Offers clinical pearls on depression treatment, including guidance on titration strategies, side effect management, and more</li>
<li>Covers the seven essential medications for effectively managing outpatient depression</li>
<li>Includes recommendations for handling DSM-5 depression as well as screening for bipolar disorder and suicide risk</li>
<li>Provides built-in calculators for measuring symptom severity using the Patient Health Questionnaire-9 item (PHQ-9) and the Columbia Depression Scale</li>
<li>Aids psychiatrists, primary care physicians, nurse practitioners, physician assistants, and trainees in making real-time psychopharmacologic decisions in outpatient settings</li>
<li>Serves as an educational tool for program directors, residents, medical students, and other trainees</li>
</ul>

Ranked among the top five psychiatry hospitals nationally by US News and receiving the #3 spot in NIH funding, Columbia University’s Department of Psychiatry boasts a rich history of over a century in academic psychiatry. The department's faculty have played pivotal roles in shaping psychiatric practices globally. Notable figures behind this clinical algorithm are J. John Mann, MD, co-director of Columbia’s Center for the Prevention and Treatment of Depression and a renowned researcher in mood disorders, along with Ravi N. Shah, MD, MBA, an influential figure in digital mental health serving as the department’s Chief Innovation Officer.

avoMD specializes in converting clinical guidelines, pathways, and algorithms into interactive decision support applications that are accessible as standalone mobile apps, web apps, or integrated within EHR systems. Hospitals and training programs nationwide are leveraging avoMD to digitalize their clinical resources and distribute them efficiently. Noteworthy supporters include Columbia University’s Lang Entrepreneurship Center, Mount Sinai Innovation Partners’ Elementa Labs, StartUp Health, and 500 Startups. The experienced team at avoMD comprises physicians and informaticians from prestigious institutions such as Columbia, Harvard, and Yale.

Subscription cost is $19.99 per year with automatic renewal unless disabled. Cancellations should be made at least 24 hours before renewal to avoid charges. Subscription management can be handled through your Apple ID account settings post-purchase.

標籤:

簡述：

安裝版本未知？

目前版本：

下載網址：

直接下載網址：

購買網址：

圖示網址：

1 擷圖網址：

2 擷圖網址：

3 擷圖網址：

4 擷圖網址：

墊檔網址：

評論：

您的電子郵件：

通訊：

請輸入您的電子郵件位址，萬一我們有對於您的貢獻有問題，我們會與您聯絡。我們絕對不會與第三方分享你的電子郵件位址。

擷圖（按一下放大）

相關產品

	UpdateStar Premium Edition UpdateStar Premium Edition：管理软件更新的实用工具 UpdateStar Premium Edition 是一种软件管理工具，旨在通过确保您的程序是最新的，帮助您的 PC 保持最佳状态。它可以处理从扫描过时软件到提供个性化推荐，甚至备份您的配置以便在需要时恢复设置的所有事情。仔细查看自动更新功能：此功能会自动扫描您的计算机以查找过时的程序，只需单击几下即可帮助您更新它们。无需再寻找每个应用程序的最新版本。软件数据库： UpdateStar …
	Microsoft Visual C++ 2015 Redistributable Package Microsoft Visual C++ 2015 Redistributable Package 是 Microsoft 创建的软件组件。它为用户提供了运行使用 Visual Studio 2015 创建的应用程序所需的运行时组件。此可再发行组件包旨在使开发人员能够更轻松地在系统上部署其应用程序，而不必担心是否已安装所需的运行时组件。该包包括 Microsoft 基础类（MFC）、Visual C++ CRT 和标准 C++ 等库。如果没有这些库，使用 Visual …
	Microsoft Edge Microsoft Edge是由Microsoft开发的Web浏览器，旨在成为市场上其他流行浏览器的轻量级和快速替代品。Microsoft Edge 于 2015 年推出，取代 Internet Explorer 成为 Windows 操作系统上的默认浏览器。 Microsoft Edge的主要功能之一是它与Microsoft的虚拟助手Cortana的集成。这允许用户在不离开浏览器窗口的情况下执行搜索、设置提醒并获取问题的答案。在性能方面，Microsoft Edge …
	Google Chrome Chrome 是 Google 开发的网络浏览器。它的特点是速度快，功能多。
	Microsoft Visual C++ 2010 Redistributable 评论：Microsoft Visual C++ 2010 Redistributable by Microsoft Microsoft Visual C++ 2010 Redistributable 是由 Microsoft 开发的软件应用程序，它为使用 Microsoft Visual C++ 2010 构建的程序提供运行时组件。在未安装 Visual C++ 2010 的计算机上运行使用此版本的 Visual …
	Microsoft Update Health Tools Microsoft Update Health Tools 是由 Microsoft Corporation 开发的软件应用程序，可帮助用户解决和修复与设备上的 Windows Update 相关的问题。作为 Microsoft 对改善 Windows 更新体验的持续承诺的一部分，更新运行状况工具旨在简化诊断和解决更新相关问题的过程。 Microsoft 更新运行状况工具的一个关键功能是它能够检测可能阻止 Windows …

瀏覽

決不會錯過的更新Columbia Psychiatry Pathways再次UpdateStar

當前時事通訊

	Calibre 使用 Calibre 輕鬆組織和管理您的電子書庫。
	Ubisoft Connect Ubisoft Connect：使用 Ubisoft 的官方平台增強您的遊戲體驗
	MiniTool Partition Wizard Free 使用 MiniTool Partition Wizard Free 輕鬆管理您的磁碟分區
	AOMEI Backupper AOMEI Backupper：可靠的備份和恢復解決方案
	EASEUS Data Recovery Wizard 使用EASEUS資料恢復精靈輕鬆恢復丟失的數據。
	FastStone Image Viewer FastStone Image Viewer：一款多功能且快速的圖像查看軟體。

Columbia Psychiatry Pathways 3.28.7

擷圖（按一下放大）

相關產品

最近的更新

最新動向

評測

瀏覽